Book Value Per Share breakdown for BiotestBook Value per Share (B/S) is can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing effects of liabilities. In other words a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of liquidation.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as good will, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Biotest Book Value Per Share Assessment
In accordance with recently published financial statements the book value per share of Biotest AG is about 31.49 times. This is 104.22% higher than that of Healthcare sector, and 459.33% higher than that of Biotechnology industry, The Book Value Per Share for all stocks is 145.82% lower than the firm.
Filter other Stocks by Book Value Per Share
Book Value Per Share ComparisonBiotest is currently under evaluation in book value per share category among related companies.
Follow Biotest Book Value Per Share with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Other Biotest Fundamentals